Structure

Physi-Chem Properties

Molecular Weight:  581.35
Volume:  628.338
LogP:  7.019
LogD:  4.823
LogS:  -4.344
# Rotatable Bonds:  3
TPSA:  79.39
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  7
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.283
Synthetic Accessibility Score:  5.247
Fsp3:  0.579
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.325
MDCK Permeability:  2.1281486624502577e-05
Pgp-inhibitor:  0.096
Pgp-substrate:  0.073
Human Intestinal Absorption (HIA):  0.043
20% Bioavailability (F20%):  0.038
30% Bioavailability (F30%):  0.815

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.366
Plasma Protein Binding (PPB):  93.9762954711914%
Volume Distribution (VD):  0.652
Pgp-substrate:  4.9607391357421875%

ADMET: Metabolism

CYP1A2-inhibitor:  0.17
CYP1A2-substrate:  0.748
CYP2C19-inhibitor:  0.441
CYP2C19-substrate:  0.366
CYP2C9-inhibitor:  0.754
CYP2C9-substrate:  0.825
CYP2D6-inhibitor:  0.878
CYP2D6-substrate:  0.135
CYP3A4-inhibitor:  0.908
CYP3A4-substrate:  0.888

ADMET: Excretion

Clearance (CL):  3.587
Half-life (T1/2):  0.113

ADMET: Toxicity

hERG Blockers:  0.139
Human Hepatotoxicity (H-HT):  0.562
Drug-inuced Liver Injury (DILI):  0.791
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.972
Maximum Recommended Daily Dose:  0.915
Skin Sensitization:  0.498
Carcinogencity:  0.95
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.985

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC284102

Natural Product ID:  NPC284102
Common Name*:   Nodulisporic Acid D3
IUPAC Name:   n.a.
Synonyms:   Nodulisporic Acid D3
Standard InCHIKey:  XCPHFIHPQDNWJO-NHHJTVBZSA-N
Standard InCHI:  InChI=1S/C38H47NO4/c1-21(33(41)42)10-9-14-36(6)30-12-11-23-18-26-25-19-24-22(16-28-27(24)20-34(2,3)43-35(28,4)5)17-29(25)39-32(26)38(23,8)37(30,7)15-13-31(36)40/h9-10,14,17,19-20,23,28,30,39H,11-13,15-16,18H2,1-8H3,(H,41,42)/b14-9+,21-10+/t23-,28-,30-,36-,37-,38+/m0/s1
SMILES:  C/C(=CC=C[C@]1(C)C(=O)CC[C@]2([C@H]1CC[C@@H]1[C@]2(C)c2[nH]c3c(c2C1)cc1c(c3)C[C@H]2C1=CC(OC2(C)C)(C)C)C)/C(=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL509735
PubChem CID:   11307760
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32628 nodulisporium Genus Xylariaceae Eukaryota n.a. n.a. n.a. PMID[15387649]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 > 1000.0 nM PMID[507586]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC284102 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9375 High Similarity NPC250129
0.9323 High Similarity NPC475165
0.9133 High Similarity NPC97388
0.9082 High Similarity NPC473547
0.9016 High Similarity NPC187456
0.8854 High Similarity NPC475151
0.8844 High Similarity NPC160527
0.8844 High Similarity NPC473650
0.875 High Similarity NPC473747
0.8689 High Similarity NPC475424
0.8689 High Similarity NPC79107
0.8578 High Similarity NPC242446
0.8578 High Similarity NPC475476
0.8537 High Similarity NPC61813
0.8436 Intermediate Similarity NPC282033
0.839 Intermediate Similarity NPC96131
0.8385 Intermediate Similarity NPC206967
0.8384 Intermediate Similarity NPC123019
0.8302 Intermediate Similarity NPC471634
0.8302 Intermediate Similarity NPC473806
0.8238 Intermediate Similarity NPC34271
0.8199 Intermediate Similarity NPC245756
0.8195 Intermediate Similarity NPC235900
0.8135 Intermediate Similarity NPC99428
0.8122 Intermediate Similarity NPC181502
0.8122 Intermediate Similarity NPC85066
0.8116 Intermediate Similarity NPC471284
0.8091 Intermediate Similarity NPC94541
0.8091 Intermediate Similarity NPC470843
0.8079 Intermediate Similarity NPC18661
0.8019 Intermediate Similarity NPC469312
0.8019 Intermediate Similarity NPC41318
0.7969 Intermediate Similarity NPC198339
0.7919 Intermediate Similarity NPC471583
0.7919 Intermediate Similarity NPC471782
0.7917 Intermediate Similarity NPC6093
0.7873 Intermediate Similarity NPC278540
0.7846 Intermediate Similarity NPC165201
0.7788 Intermediate Similarity NPC183426
0.7783 Intermediate Similarity NPC32200
0.7727 Intermediate Similarity NPC119700
0.7708 Intermediate Similarity NPC97525
0.7699 Intermediate Similarity NPC311451
0.7656 Intermediate Similarity NPC6982
0.7615 Intermediate Similarity NPC235885
0.7588 Intermediate Similarity NPC160381
0.7571 Intermediate Similarity NPC470280
0.7563 Intermediate Similarity NPC302191
0.7558 Intermediate Similarity NPC2395
0.7556 Intermediate Similarity NPC473565
0.7551 Intermediate Similarity NPC213468
0.7549 Intermediate Similarity NPC231342
0.7547 Intermediate Similarity NPC204303
0.7512 Intermediate Similarity NPC46413
0.75 Intermediate Similarity NPC184476
0.7488 Intermediate Similarity NPC127677
0.7488 Intermediate Similarity NPC258062
0.7487 Intermediate Similarity NPC472587
0.7464 Intermediate Similarity NPC98715
0.7463 Intermediate Similarity NPC11445
0.745 Intermediate Similarity NPC476319
0.745 Intermediate Similarity NPC280290
0.7441 Intermediate Similarity NPC46225
0.7441 Intermediate Similarity NPC225821
0.7423 Intermediate Similarity NPC280548
0.7415 Intermediate Similarity NPC195239
0.7415 Intermediate Similarity NPC157828
0.7397 Intermediate Similarity NPC280799
0.7393 Intermediate Similarity NPC131273
0.7393 Intermediate Similarity NPC473441
0.7374 Intermediate Similarity NPC270009
0.7371 Intermediate Similarity NPC271862
0.7371 Intermediate Similarity NPC154293
0.7358 Intermediate Similarity NPC474905
0.7352 Intermediate Similarity NPC470874
0.7349 Intermediate Similarity NPC475778
0.7347 Intermediate Similarity NPC34508
0.7336 Intermediate Similarity NPC234999
0.7333 Intermediate Similarity NPC137589
0.733 Intermediate Similarity NPC51388
0.7327 Intermediate Similarity NPC203614
0.7327 Intermediate Similarity NPC204491
0.7324 Intermediate Similarity NPC39679
0.7317 Intermediate Similarity NPC47190
0.7315 Intermediate Similarity NPC31700
0.7296 Intermediate Similarity NPC126492
0.7295 Intermediate Similarity NPC205403
0.7286 Intermediate Similarity NPC300183
0.7277 Intermediate Similarity NPC274640
0.7269 Intermediate Similarity NPC87856
0.7269 Intermediate Similarity NPC151976
0.7268 Intermediate Similarity NPC71132
0.7248 Intermediate Similarity NPC132211
0.7235 Intermediate Similarity NPC267965
0.7234 Intermediate Similarity NPC124005
0.7233 Intermediate Similarity NPC55493
0.7232 Intermediate Similarity NPC57690
0.7222 Intermediate Similarity NPC87413
0.7222 Intermediate Similarity NPC9894
0.722 Intermediate Similarity NPC329858
0.7217 Intermediate Similarity NPC476115
0.7212 Intermediate Similarity NPC474701
0.7211 Intermediate Similarity NPC200743
0.7202 Intermediate Similarity NPC473320
0.7196 Intermediate Similarity NPC477065
0.719 Intermediate Similarity NPC241024
0.7186 Intermediate Similarity NPC288785
0.7178 Intermediate Similarity NPC19679
0.7175 Intermediate Similarity NPC147446
0.7173 Intermediate Similarity NPC38736
0.717 Intermediate Similarity NPC162730
0.717 Intermediate Similarity NPC474116
0.7165 Intermediate Similarity NPC16667
0.7156 Intermediate Similarity NPC470873
0.7156 Intermediate Similarity NPC214428
0.7143 Intermediate Similarity NPC141428
0.7136 Intermediate Similarity NPC314333
0.7136 Intermediate Similarity NPC477135
0.7129 Intermediate Similarity NPC192270
0.7128 Intermediate Similarity NPC129042
0.7128 Intermediate Similarity NPC8104
0.7123 Intermediate Similarity NPC118228
0.7112 Intermediate Similarity NPC475844
0.7111 Intermediate Similarity NPC472762
0.7108 Intermediate Similarity NPC473189
0.71 Intermediate Similarity NPC84347
0.7098 Intermediate Similarity NPC266192
0.7094 Intermediate Similarity NPC472444
0.7091 Intermediate Similarity NPC3207
0.7087 Intermediate Similarity NPC196251
0.7087 Intermediate Similarity NPC102338
0.7087 Intermediate Similarity NPC63199
0.7087 Intermediate Similarity NPC111602
0.7081 Intermediate Similarity NPC220151
0.7081 Intermediate Similarity NPC195314
0.7081 Intermediate Similarity NPC19692
0.708 Intermediate Similarity NPC469720
0.708 Intermediate Similarity NPC476491
0.7077 Intermediate Similarity NPC214106
0.7075 Intermediate Similarity NPC49196
0.7075 Intermediate Similarity NPC195461
0.7075 Intermediate Similarity NPC79129
0.7075 Intermediate Similarity NPC81654
0.7075 Intermediate Similarity NPC249150
0.7075 Intermediate Similarity NPC313985
0.7075 Intermediate Similarity NPC252338
0.7073 Intermediate Similarity NPC235684
0.707 Intermediate Similarity NPC300156
0.707 Intermediate Similarity NPC277350
0.7067 Intermediate Similarity NPC67551
0.7062 Intermediate Similarity NPC67056
0.7062 Intermediate Similarity NPC477044
0.7062 Intermediate Similarity NPC477041
0.7061 Intermediate Similarity NPC290529
0.7059 Intermediate Similarity NPC293151
0.7056 Intermediate Similarity NPC470509
0.7054 Intermediate Similarity NPC144452
0.7053 Intermediate Similarity NPC83111
0.7053 Intermediate Similarity NPC469497
0.7053 Intermediate Similarity NPC106833
0.7048 Intermediate Similarity NPC472293
0.7048 Intermediate Similarity NPC245916
0.7041 Intermediate Similarity NPC271734
0.704 Intermediate Similarity NPC174760
0.7037 Intermediate Similarity NPC4687
0.7035 Intermediate Similarity NPC267926
0.703 Intermediate Similarity NPC472443
0.7028 Intermediate Similarity NPC476175
0.7027 Intermediate Similarity NPC82070
0.7027 Intermediate Similarity NPC184408
0.7023 Intermediate Similarity NPC477043
0.7021 Intermediate Similarity NPC242556
0.7018 Intermediate Similarity NPC475422
0.7014 Intermediate Similarity NPC469928
0.7014 Intermediate Similarity NPC330009
0.7005 Intermediate Similarity NPC246700
0.7005 Intermediate Similarity NPC128751
0.7004 Intermediate Similarity NPC249342
0.7 Intermediate Similarity NPC477134
0.6995 Remote Similarity NPC471458
0.6995 Remote Similarity NPC199851
0.6995 Remote Similarity NPC128265
0.6995 Remote Similarity NPC312870
0.6995 Remote Similarity NPC294909
0.6995 Remote Similarity NPC254240
0.6995 Remote Similarity NPC300688
0.6991 Remote Similarity NPC476818
0.6987 Remote Similarity NPC474688
0.6986 Remote Similarity NPC472292
0.6983 Remote Similarity NPC6786
0.6982 Remote Similarity NPC312645
0.6981 Remote Similarity NPC67288
0.6981 Remote Similarity NPC52557
0.6981 Remote Similarity NPC50503
0.698 Remote Similarity NPC151939
0.6977 Remote Similarity NPC134848
0.6971 Remote Similarity NPC472112
0.6963 Remote Similarity NPC471944
0.6963 Remote Similarity NPC37548
0.6963 Remote Similarity NPC187951

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC284102 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7879 Intermediate Similarity NPD6630 Clinical (unspecified phase)
0.7512 Intermediate Similarity NPD5003 Discontinued
0.7444 Intermediate Similarity NPD7688 Phase 1
0.7443 Intermediate Similarity NPD6995 Phase 1
0.7381 Intermediate Similarity NPD2920 Discontinued
0.7346 Intermediate Similarity NPD5901 Discontinued
0.7304 Intermediate Similarity NPD2564 Approved
0.7304 Intermediate Similarity NPD2565 Phase 2
0.7282 Intermediate Similarity NPD2844 Phase 3
0.7256 Intermediate Similarity NPD7998 Clinical (unspecified phase)
0.7183 Intermediate Similarity NPD56 Approved
0.7183 Intermediate Similarity NPD8283 Approved
0.7183 Intermediate Similarity NPD8282 Approved
0.7179 Intermediate Similarity NPD5744 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD7947 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD8248 Clinical (unspecified phase)
0.7136 Intermediate Similarity NPD6176 Phase 1
0.7136 Intermediate Similarity NPD4499 Approved
0.7114 Intermediate Similarity NPD5398 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD7455 Approved
0.711 Intermediate Similarity NPD7454 Approved
0.7094 Intermediate Similarity NPD5728 Clinical (unspecified phase)
0.7087 Intermediate Similarity NPD1534 Approved
0.7083 Intermediate Similarity NPD8423 Phase 2
0.7083 Intermediate Similarity NPD8399 Phase 1
0.7078 Intermediate Similarity NPD8094 Discontinued
0.7075 Intermediate Similarity NPD4601 Approved
0.7075 Intermediate Similarity NPD4600 Approved
0.7071 Intermediate Similarity NPD1326 Approved
0.7071 Intermediate Similarity NPD1325 Approved
0.707 Intermediate Similarity NPD7010 Phase 3
0.7059 Intermediate Similarity NPD3607 Clinical (unspecified phase)
0.7054 Intermediate Similarity NPD6160 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD5834 Phase 3
0.7051 Intermediate Similarity NPD5835 Phase 3
0.7039 Intermediate Similarity NPD8431 Approved
0.7032 Intermediate Similarity NPD8093 Discontinued
0.7023 Intermediate Similarity NPD6987 Phase 1
0.6995 Remote Similarity NPD4501 Approved
0.6995 Remote Similarity NPD6479 Discontinued
0.6995 Remote Similarity NPD4500 Approved
0.6991 Remote Similarity NPD4862 Clinical (unspecified phase)
0.6986 Remote Similarity NPD7470 Discontinued
0.6959 Remote Similarity NPD5429 Discontinued
0.6957 Remote Similarity NPD4948 Discontinued
0.6948 Remote Similarity NPD6248 Phase 2
0.6948 Remote Similarity NPD6249 Phase 2
0.6948 Remote Similarity NPD6661 Clinical (unspecified phase)
0.6944 Remote Similarity NPD6138 Clinical (unspecified phase)
0.6943 Remote Similarity NPD7824 Approved
0.6937 Remote Similarity NPD8160 Phase 2
0.693 Remote Similarity NPD5721 Clinical (unspecified phase)
0.6926 Remote Similarity NPD7953 Approved
0.6926 Remote Similarity NPD7952 Approved
0.6926 Remote Similarity NPD7951 Approved
0.6926 Remote Similarity NPD7789 Approved
0.6926 Remote Similarity NPD7791 Approved
0.6926 Remote Similarity NPD7790 Approved
0.6926 Remote Similarity NPD7950 Approved
0.6923 Remote Similarity NPD7234 Approved
0.6923 Remote Similarity NPD4334 Discontinued
0.6923 Remote Similarity NPD7233 Approved
0.6912 Remote Similarity NPD5473 Discontinued
0.6912 Remote Similarity NPD7958 Clinical (unspecified phase)
0.6912 Remote Similarity NPD7957 Phase 1
0.69 Remote Similarity NPD7781 Approved
0.69 Remote Similarity NPD7780 Approved
0.6895 Remote Similarity NPD7941 Phase 3
0.6892 Remote Similarity NPD8112 Clinical (unspecified phase)
0.6892 Remote Similarity NPD7707 Approved
0.6884 Remote Similarity NPD4554 Clinical (unspecified phase)
0.6881 Remote Similarity NPD6838 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7395 Discontinued
0.6866 Remote Similarity NPD6739 Clinical (unspecified phase)
0.6861 Remote Similarity NPD3394 Approved
0.6861 Remote Similarity NPD3389 Approved
0.6861 Remote Similarity NPD3393 Approved
0.6856 Remote Similarity NPD7731 Approved
0.6856 Remote Similarity NPD5086 Approved
0.6856 Remote Similarity NPD7730 Approved
0.6849 Remote Similarity NPD2509 Approved
0.6849 Remote Similarity NPD2510 Approved
0.6849 Remote Similarity NPD6376 Discontinued
0.6847 Remote Similarity NPD749 Clinical (unspecified phase)
0.6845 Remote Similarity NPD2095 Phase 2
0.6845 Remote Similarity NPD2092 Phase 2
0.6845 Remote Similarity NPD2094 Phase 2
0.6839 Remote Similarity NPD4462 Approved
0.6839 Remote Similarity NPD4463 Approved
0.6833 Remote Similarity NPD7927 Clinical (unspecified phase)
0.6829 Remote Similarity NPD8464 Clinical (unspecified phase)
0.6826 Remote Similarity NPD7767 Approved
0.6822 Remote Similarity NPD7946 Pre-registration
0.6812 Remote Similarity NPD2096 Phase 2
0.6812 Remote Similarity NPD2091 Phase 2
0.6806 Remote Similarity NPD4511 Phase 1
0.6806 Remote Similarity NPD7931 Approved
0.6806 Remote Similarity NPD7934 Discovery
0.6806 Remote Similarity NPD7933 Approved
0.6806 Remote Similarity NPD7932 Clinical (unspecified phase)
0.6802 Remote Similarity NPD6657 Clinical (unspecified phase)
0.6798 Remote Similarity NPD7716 Approved
0.6798 Remote Similarity NPD7717 Approved
0.6798 Remote Similarity NPD482 Approved
0.6791 Remote Similarity NPD3800 Clinical (unspecified phase)
0.6789 Remote Similarity NPD6323 Clinical (unspecified phase)
0.6787 Remote Similarity NPD7825 Clinical (unspecified phase)
0.6783 Remote Similarity NPD7268 Clinical (unspecified phase)
0.6783 Remote Similarity NPD6292 Clinical (unspecified phase)
0.678 Remote Similarity NPD8386 Phase 2
0.678 Remote Similarity NPD4076 Approved
0.678 Remote Similarity NPD4079 Approved
0.6777 Remote Similarity NPD5913 Phase 3
0.6777 Remote Similarity NPD5912 Clinical (unspecified phase)
0.6777 Remote Similarity NPD3785 Clinical (unspecified phase)
0.6774 Remote Similarity NPD7187 Phase 2
0.6769 Remote Similarity NPD7271 Approved
0.6763 Remote Similarity NPD3318 Approved
0.6763 Remote Similarity NPD3320 Approved
0.6763 Remote Similarity NPD3319 Phase 1
0.6758 Remote Similarity NPD6245 Phase 2
0.6754 Remote Similarity NPD5254 Discontinued
0.675 Remote Similarity NPD8358 Approved
0.6749 Remote Similarity NPD4112 Clinical (unspecified phase)
0.6745 Remote Similarity NPD4315 Phase 2
0.6744 Remote Similarity NPD53 Approved
0.6744 Remote Similarity NPD7777 Approved
0.6744 Remote Similarity NPD7778 Approved
0.6743 Remote Similarity NPD5487 Phase 1
0.6743 Remote Similarity NPD2121 Clinical (unspecified phase)
0.6742 Remote Similarity NPD4506 Discontinued
0.6737 Remote Similarity NPD1592 Phase 3
0.6735 Remote Similarity NPD5257 Clinical (unspecified phase)
0.6732 Remote Similarity NPD3506 Approved
0.6732 Remote Similarity NPD3505 Approved
0.6732 Remote Similarity NPD7865 Approved
0.673 Remote Similarity NPD6281 Approved
0.6729 Remote Similarity NPD5512 Phase 3
0.6727 Remote Similarity NPD7562 Approved
0.6726 Remote Similarity NPD7878 Phase 2
0.6712 Remote Similarity NPD8098 Approved
0.6711 Remote Similarity NPD7218 Clinical (unspecified phase)
0.6698 Remote Similarity NPD6664 Approved
0.6698 Remote Similarity NPD6206 Phase 1
0.6697 Remote Similarity NPD8073 Approved
0.6697 Remote Similarity NPD2916 Discontinued
0.6696 Remote Similarity NPD6770 Approved
0.6696 Remote Similarity NPD3925 Approved
0.6683 Remote Similarity NPD4345 Clinical (unspecified phase)
0.6683 Remote Similarity NPD6375 Clinical (unspecified phase)
0.6683 Remote Similarity NPD5021 Discontinued
0.6682 Remote Similarity NPD2715 Clinical (unspecified phase)
0.6682 Remote Similarity NPD5475 Discontinued
0.6682 Remote Similarity NPD5975 Clinical (unspecified phase)
0.6682 Remote Similarity NPD5416 Discontinued
0.6667 Remote Similarity NPD5898 Approved
0.6667 Remote Similarity NPD6261 Phase 3
0.6667 Remote Similarity NPD5897 Approved
0.6667 Remote Similarity NPD6182 Approved
0.6667 Remote Similarity NPD6183 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3746 Discontinued
0.6667 Remote Similarity NPD43 Approved
0.6667 Remote Similarity NPD5899 Approved
0.6667 Remote Similarity NPD7921 Approved
0.6652 Remote Similarity NPD8405 Clinical (unspecified phase)
0.6638 Remote Similarity NPD5506 Approved
0.6638 Remote Similarity NPD5507 Approved
0.6637 Remote Similarity NPD6733 Discontinued
0.6636 Remote Similarity NPD3947 Discontinued
0.6636 Remote Similarity NPD5426 Phase 3
0.6635 Remote Similarity NPD4383 Clinical (unspecified phase)
0.6627 Remote Similarity NPD8364 Approved
0.6627 Remote Similarity NPD8363 Approved
0.6622 Remote Similarity NPD7571 Clinical (unspecified phase)
0.6622 Remote Similarity NPD3794 Approved
0.6622 Remote Similarity NPD3795 Approved
0.6618 Remote Similarity NPD3417 Phase 1
0.6617 Remote Similarity NPD1631 Approved
0.6607 Remote Similarity NPD8013 Clinical (unspecified phase)
0.6606 Remote Similarity NPD4901 Clinical (unspecified phase)
0.6603 Remote Similarity NPD5522 Clinical (unspecified phase)
0.6602 Remote Similarity NPD5104 Approved
0.6602 Remote Similarity NPD4075 Phase 2
0.6593 Remote Similarity NPD5417 Clinical (unspecified phase)
0.6591 Remote Similarity NPD8072 Approved
0.659 Remote Similarity NPD6846 Clinical (unspecified phase)
0.6588 Remote Similarity NPD5444 Phase 1
0.6588 Remote Similarity NPD5809 Phase 3
0.6585 Remote Similarity NPD750 Phase 2
0.6583 Remote Similarity NPD7770 Phase 3
0.6578 Remote Similarity NPD7594 Clinical (unspecified phase)
0.6575 Remote Similarity NPD8365 Clinical (unspecified phase)
0.6575 Remote Similarity NPD6145 Phase 1
0.6571 Remote Similarity NPD6178 Phase 3
0.657 Remote Similarity NPD2144 Approved
0.6569 Remote Similarity NPD8016 Phase 3
0.6569 Remote Similarity NPD8017 Clinical (unspecified phase)
0.6568 Remote Similarity NPD5040 Clinical (unspecified phase)
0.6567 Remote Similarity NPD6977 Clinical (unspecified phase)
0.6567 Remote Similarity NPD972 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data